# Efficacy And Security Of Annual And Biennial Zoledronic Acid For Osteoporosis Treatment In An HIV-Infected Patients' Cohort

> **NCT00795483** · PHASE4 · COMPLETED · sponsor: **Germans Trias i Pujol Hospital** · enrollment: 33 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Zoledronic acid
- **BEHAVIORAL:** Lifestyle modifications
- **DRUG:** Zoledronic acid

## Key facts

- **NCT ID:** NCT00795483
- **Lead sponsor:** Germans Trias i Pujol Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2020-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00795483

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00795483, "Efficacy And Security Of Annual And Biennial Zoledronic Acid For Osteoporosis Treatment In An HIV-Infected Patients' Cohort". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00795483. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*